Engineered platelets can induce anti-inflammatory, immunosuppressive response, finds scientist

by Marlene Leung,St. Michael's HospitalCredit: Pixabay/CC0 Public DomainNew research led by a St. Michael's Hospital scientist reveals how platelets can inhibit inflammation and immune r

Updated on: January 27,2024 11

Engineered platelets can induce anti-inflammatory, immunosuppressive response, finds scientist

by Marlene Leung,St. Michael's HospitalCredit: Pixabay/CC0 Public DomainNew research led by a St. Michael's Hospital scientist reveals how platelets can inhibit inflammation and immune r

Updated on:January 27,2024 11

Making clinical guidelines work for large language models

by Rachel Martin,Yale UniversityExample of a clinical decision support system integrated with large language models. Credit:npj Digital Medicine(2024). DOI: 10.1038/s41746-024-01091-

Updated on: July 23,2024 0

Making clinical guidelines work for large language models

by Rachel Martin,Yale UniversityExample of a clinical decision support system integrated with large language models. Credit:npj Digital Medicine(2024). DOI: 10.1038/s41746-024-01091-

Updated on:July 23,2024 0

One in five US cancer patients join in medical research

by Dennis ThompsonMore patients these days are taking part in cancer research, a new study finds.At least one in five people with cancer (22%) participate in some form of clinical research, when all t

Updated on: April 06,2024 0

One in five US cancer patients join in medical research

by Dennis ThompsonMore patients these days are taking part in cancer research, a new study finds.At least one in five people with cancer (22%) participate in some form of clinical research, when all t

Updated on:April 06,2024 0

How an Addicted Brain Works

Updated on: August 26,2024 0

How an Addicted Brain Works

Updated on:August 26,2024 0

Study discovers how a magnesium cellular transport 'pump' plays a vital role in cardiac function

by Steven Lee,University of Texas Health Science Center at San AntonioCredit:Molecular Cell(2024). DOI: 10.1016/j.molcel.2024.02.033Magnesium is a mineral critical to a wide range of

Updated on: March 30,2024 0

Study discovers how a magnesium cellular transport 'pump' plays a vital role in cardiac function

by Steven Lee,University of Texas Health Science Center at San AntonioCredit:Molecular Cell(2024). DOI: 10.1016/j.molcel.2024.02.033Magnesium is a mineral critical to a wide range of

Updated on:March 30,2024 0

World-first human trial finds arthritis drug can suppress progression of type 1 diabetes

DECEMBER 6, 2023bySt Vincent's Institute of Medical ResearchCredit: CC0 Public DomainResearchers at St Vincent's Institute of Medical Research (SVI) in Melbourne have shown that a common

Updated on: March 25,2024 4

World-first human trial finds arthritis drug can suppress progression of type 1 diabetes

DECEMBER 6, 2023bySt Vincent's Institute of Medical ResearchCredit: CC0 Public DomainResearchers at St Vincent's Institute of Medical Research (SVI) in Melbourne have shown that a common

Updated on:March 25,2024 4

New compound shows early promise for treatment of Lou Gehrig's disease in preclinical models

NOVEMBER 7, 2023by Jaclyn Dunne,Medical University of South CarolinaMitochondrial membrane rearrangements are critical in recruiting p17/PERMIT-CerS1 to mitochondria. Credit:Aging Cell&nbs

Updated on: March 25,2024 6

New compound shows early promise for treatment of Lou Gehrig's disease in preclinical models

NOVEMBER 7, 2023by Jaclyn Dunne,Medical University of South CarolinaMitochondrial membrane rearrangements are critical in recruiting p17/PERMIT-CerS1 to mitochondria. Credit:Aging Cell&nbs

Updated on:March 25,2024 6

Research provides further evidence that epigenetic changes can cause type 2 diabetes

byLund UniversityStudy design. EPIC array DNA methylation in islets of 25 T2D cases and 75 controls. RNA-seq data were available for 25 T2D cases and 72 controls. Islet DNA methylation was assoc

Updated on: March 13,2024 5

Research provides further evidence that epigenetic changes can cause type 2 diabetes

byLund UniversityStudy design. EPIC array DNA methylation in islets of 25 T2D cases and 75 controls. RNA-seq data were available for 25 T2D cases and 72 controls. Islet DNA methylation was assoc

Updated on:March 13,2024 5

AI model provides deep insights into hand movement, an essential step for development of neuroprosthetics

byEcole Polytechnique Federale de LausanneThe EPFL/UNIGE AI model achieved a 100% success rate in the first phase of the competition, surpassing the closest competitor. Even in the more challeng

Updated on: October 21,2024 0

AI model provides deep insights into hand movement, an essential step for development of neuroprosthetics

byEcole Polytechnique Federale de LausanneThe EPFL/UNIGE AI model achieved a 100% success rate in the first phase of the competition, surpassing the closest competitor. Even in the more challeng

Updated on:October 21,2024 0

Drug development advances in beneficial loss-of-function mutation targets validated by human genetics

by Sichuan International Medical Exchange and Promotion AssociationTargets primarily include PCSK9, ANGPTL3, HSD17B13, KHK, ASGR1, GPR75, CIDEB, and INHBE. Drug types primarily include small molecules

Updated on: March 28,2024 0

Drug development advances in beneficial loss-of-function mutation targets validated by human genetics

by Sichuan International Medical Exchange and Promotion AssociationTargets primarily include PCSK9, ANGPTL3, HSD17B13, KHK, ASGR1, GPR75, CIDEB, and INHBE. Drug types primarily include small molecules

Updated on:March 28,2024 0

Why MDMA did NOT get FDA approval

Updated on: September 01,2024 0

Why MDMA did NOT get FDA approval

Updated on:September 01,2024 0

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on: August 12,2024 0

FDA Approves Lymphir: A New Hope for CTCL Patients

The U.S. Food and Drug Administration (FDA) had approved Lymphir (denileukin diftitox-cxdl), a novel immunotherapy for the treatment of relapsed or refractory cutaneous T-cell lymphoma (CTCL) after at least one prior systemic therapy.

Updated on:August 12,2024 0